FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...
Please provide your email address to receive an email when new articles are posted on . Spirometry, treatments, telemedicine and multimorbidity are notable topics at this year’s GOLD International ...
WAYNETOWN, Ind. — Tony Manion doesn't miss a workout. Seriously. Three hours a day, every day. "You just make a choice to do it," Manion said, between reps from his home gym in rural Montgomery County ...
Recent medical research is reshaping our understanding of Chronic Obstructive Pulmonary Disease (COPD), particularly highlighting its disproportionate impact on women. This shift in the COPD landscape ...
November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...
May 23, 2025 -- The FDA has approved the asthma drug Nucala for adults with chronic obstructive pulmonary disease (COPD). It is the second biologic therapy approved for the condition, following the ...
Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...
Onlymyhealth on MSN
Breathless While Talking or Climbing Few Steps? Know Early COPD Signs People Shouldn't Ignore Here
If you often feel short of breath when you talk, walk a short distance, or use the stairs, you might think it is just a result of the lack of fitness, stress, or age. However, it is high time the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results